Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis

BACKGROUND: Data on safety and efficacy of voriconazole for invasive aspergillosis (IA) and invasive candidiasis/esophageal candidiasis (IC/EC) in pediatric patients are limited. METHODS: Patients aged 2–<18 years with IA and IC/EC were enrolled in 2 prospective open-label, non-comparative studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Judith M., Macias-Parra, Mercedes, Mudry, Peter, Conte, Umberto, Yan, Jean L., Liu, Ping, Capparella, M. Rita, Aram, Jalal A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Williams & Wilkins 2017
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345593/
https://www.ncbi.nlm.nih.gov/pubmed/27636722
http://dx.doi.org/10.1097/INF.0000000000001339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345593/
https://www.ncbi.nlm.nih.gov/pubmed/27636722
http://dx.doi.org/10.1097/INF.0000000000001339

Ejemplares similares